AstraZeneca ended last year as the world’s seventh largest pharma company by market cap – but as the leading group when it comes to starting clinical trials. Last year AstraZeneca kicked off 139 trials, the majority in cancer indications, beating Pfizer into second place.
AstraZeneca Leads The Way In Clinical Trials
The UK group began more clinical trials last year than any other company, a new report from Citeline has found.
